Shares of Sun Pharmaceutical
Industries today fell by over 3 per cent after the company
reported a 59.19 per cent decline in consolidated net profit
for the September quarter.
The stock slipped 3.29 per cent to Rs 508.80 on the BSE.
At the NSE, it fell 3.32 per cent to Rs 508.55.
Pharma major Sun Pharmaceutical Industries yesterday
reported a 59.19 per cent drop in consolidated net profit to
Rs 912.12 crore for the September quarter, mainly on account
of degrowth in the US sales.
The company had posted a net profit of Rs 2,235.14 crore
for the corresponding period of the previous fiscal, Sun
Pharma said in a BSE filing.
Consolidated total revenue from operations stood at Rs
6,650.34 crore. It was Rs 8,260.11 crore in the same period of
the previous year.